One-Stop In Vitro Diagnostics (IVD) CDMO Partner | From Lab to Market
Expert Call: (86) 23-86916205
Submit Project Inquiry

News & Insights

Home
News & Insights
Why IVD CDMO Is Reshaping the Future of Diagnostic Product Commercialization
19Jun 2026
CDMO Insights, Industry News IVDCDMO Team Comments: 0

Why IVD CDMO Is Reshaping the Future of Diagnostic Product Commercialization

How End-to-End IVD CDMO Services Reduce Development Costs, Accelerate Regulatory Approval, and Improve Market Success The global in vitro diagnostics (IVD) industry is undergoing rapid transformation. As healthcare systems demand faster innovation, shorter development cycles, and stricter regulatory compliance, many diagnostic companies are rethinking how new products are brought to market. Traditionally, diagnostic manufacturers built their own research teams, established production facilities,...
Read More
From $100 Million to $1,000 How Gene Sequencing Became Accessible to Everyone
12Jun 2026
News & Insights IVDCDMO Team Comments: 0

From $100 Million to $1,000: How Gene Sequencing Became Accessible to Everyone

The Extraordinary Journey of Gene Sequencing Technology In 2001, when the first draft of the human genome was unveiled, it marked one of the most significant scientific achievements in modern history. The international Human Genome Project spanned more than a decade, mobilized thousands of researchers worldwide, and posted an overall total investment exceeding $2.7 billion. Early commercial whole-human-genome sequencing based on first-generation Sanger chemistry carried a sticker price of roughl...
Read More
The Rise of Chinese Manufacturing and Its Long-Term Impact on Global IVD Production: A Structural Shift in Healthcare Supply Chains
03Jun 2026
Industry News IVDCDMO Team Comments: 0

The Rise of Chinese Manufacturing and Its Long-Term Impact on Global IVD Production: A Structural Shift in Healthcare Supply Chains

Over the past two decades, China has evolved from a low-cost manufacturing destination into the world’s largest industrial production powerhouse. What began with consumer goods and electronics has progressively expanded into high-value sectors including medical devices, pharmaceuticals, biotechnology, laboratory equipment, and in vitro diagnostics (IVD). The implications extend far beyond manufacturing economics. The global healthcare supply chain is undergoing a structural reconfiguration...
Read More
IVD Contract Manufacturing Market Trends: Why Outsourced Diagnostics Manufacturing Is Entering a More Strategic Era
01Jun 2026
Industry News IVDCDMO Team Comments: 0

IVD Contract Manufacturing Market Trends: Why Outsourced Diagnostics Manufacturing Is Entering a More Strategic Era

The IVD Contract Manufacturing Market: A Fully Corrected and Enhanced Analysis 1. Market Growth Is Being Driven by Structural Outsourcing, Not Just Capacity Gaps The global IVD contract manufacturing market has reached a scale of tens of billions of dollars. Multiple market research reports show steady high single-digit to low double-digit annual growth in recent years. This performance proves that outsourcing was never merely a short-term solution to production shortages; it has evolved into a...
Read More
From Treatment to Diagnosis Why the Future of Global Healthcare Will Be Defined by IVD and Precision Diagnostics
12May 2026
News & Insights IVDCDMO Team Comments: 0

From Treatment to Diagnosis: Why the Future of Global Healthcare Will Be Defined by IVD and Precision Diagnostics

For more than a century, modern healthcare systems have been fundamentally organized around one dominant principle: treating disease after symptoms emerge. Hospitals, pharmaceutical companies, insurance systems, and clinical workflows were largely designed to intervene once illness had already progressed into a detectable and often costly condition. That paradigm is now changing. Across the global healthcare industry, a profound structural transition is underway — from reactive treatment towar...
Read More
11May 2026
News & Insights IVDCDMO Team Comments: 0

High-Affinity Antibody Development for POCT, ELISA, CLIA and Lateral Flow IVD Platforms

The components are transferred to a very acidic lysosome and are eventually degraded through specialized enzymes. Technologyers can exploit these processes to change...
Read More
11May 2026
News & Insights IVDCDMO Team Comments: 0

How to Launch POCT & ELISA IVD Products Under IVDR and FDA 510(k) Compliance

The governments with the most successful outcomes followed rules given by the WHO. Additionally, they worked with their citizens to make sure that as many people...
Read More
11May 2026
News & Insights IVDCDMO Team Comments: 0

Beyond AlphaFold: How Phase Oscillators Are Revolutionizing Protein Dynamics Simulation

With 200 access points across the country a comprehensive logistics network, we have proven to be an important partner in the response to COVID-19, having governments with the most successful outcomes followed rules given...
Read More